Express Scripts’ $25 insulin cap led to lower costs, better adherence to diabetes treatment, study finds

(by Jakob Emerson for Becker’s Hospital Review)

Express Scripts’ $25 insulin cap program has slashed patient cost-sharing in half and improved diabetes treatment adherence, according to a new study published June 16 by Cigna health services subsidiary Evernorth. Continue reading here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org